Daniel M. Geynisman, MD, Joins Fox Chase Cancer Center’s Department of Medical Oncology

PHILADELPHIA, PA (July 25, 2013)—Daniel M. Geynisman, MD, has joined Fox Chase’s department of medical oncology after completing a hematology/oncology fellowship at the University of Chicago Medical Center, where he served as chief fellow in his final year. While there, he completed an additional fellowship at the MacLean Center for Clinical Medical Ethics. He specializes in treating patients with genitourinary cancers, including prostate, bladder, kidney, testicular, penile, and adrenal cancers.

Dr. Geynisman earned his medical degree from the University of Pittsburgh School of Medicine and completed a residency in internal medicine at the University of Pittsburgh Medical Center, serving an additional year as chief resident. Before enrolling in medical school, he worked as a mental health counselor at Linden Oaks Hospital in Naperville, Ill., having received his undergraduate degree in psychology from Northwestern University.

Dr. Geynisman’s research focuses on health outcomes, such as adherence to oral anticancer drugs; medical ethics; and clinical trials development for genitourinary cancers. He is fluent in Russian as well as English.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text